ADHD is a common childhood disorder that can continue into adulthood, and
there is limited information about diagnosis and treatment in adults. This
survey is some of it.
The scale
| US adults with an ADHD diagnosis (2023) | an estimated 15.5 million |
| Diagnosed in adulthood | approximately half |
| Taking stimulant medication | approximately one third |
| Had ever used telehealth for ADHD services | approximately half |
Half diagnosed as adults is the figure that reframes the condition. ADHD is
described as a childhood disorder that can persist; for half of these people
it was never identified in childhood at all.
The shortage
**71.5% had difficulty filling their prescription because the medication was
unavailable.**
Seven in ten. Not cost, not insurance, not a prescribing dispute — **the
medicine was not there.**
Stimulants are controlled substances with production quotas, and the shortages
of recent years have meant patients going from pharmacy to pharmacy, rationing
doses, or going without. For a medication taken daily to function at work,
that is not an inconvenience.
Why the CDC is measuring this
**Information on diagnosis and treatment helps the development of clinical
care guidelines and regulatory decision-making around medication shortages
and telehealth for ADHD.**
Both of those policy questions were live when this survey ran. Telehealth
prescribing of controlled substances was expanded during the pandemic and its
future was under review — and **half of these adults had used telehealth for
ADHD services.** A regulatory decision on that reaches millions of people, and
until surveys like this there was almost no data on how many.
*Source: Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and
Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys
System, United States, October–November 2023. MMWR, Centers for Disease
Control and Prevention.*
ライセンス： CC0 1.0（パブリックドメイン） · 出典 www.cdc.gov
1
0
0
0
コメント
次に読む
